Vetter has opened a new office in Tokyo, Japan, its second in the Asia-Pacific region.
Hiroaki Suzuki will lead Vetter's business activities in Japan in his role as Business Development Manager for Vetter Pharma International Japan. He reports to Chervee Ho, Director Key Account Management Asia-Pacific, who is based in Singapore.
Vetter says the new office underlines the importance of Japan for its business. As the second-largest pharmaceutical single market, it is home to a number of leading global companies which offer a promising injectable pipeline. It is also a point of departure for several established Japanese companies for increasing their global reach.
Our presence in Japan will help to increase awareness of Vetter’s services in this growing healthcare market
The German firm says the new office will support customer relations and aid in the development of new business within Japan, while strengthening its global position, particularly in selected Asia Pacific markets.
'For more than 35 years, the name Vetter has been synonymous with high-quality aseptically prefilled drug-delivery systems. With our office opening in Japan, we continue to build upon that history with a further demonstration of our strategy to better service the needs of our growing customer base worldwide, including Asia,' said Udo Vetter, Chairman of the Advisory Board.
Vetter's Managing Director Peter Soelkner added: 'Our presence in Japan will help to increase awareness of Vetter’s services in this growing healthcare market by presenting our expertise and market position onsite.
'Following the creation of our Asia-Pacific hub in Singapore last year, the new office is a further development, establishing a dedicated presence in the most important single market of the region.'
'Vetter’s decision to expand their presence in the Asia-Pacific region and to open their first office in Japan is a strong message of their commitment to service the needs of this important market,' said Dr Hitoshi Kuboniwa, Senior Vice President and General Manager of Pharmaceutical Technology Division at Chugai Pharmaceutical, one of Vetter's partners.
